Showing results (501-510 of 6,709) with videos related to
Sort By:
Pageof 671
Oncotargets and Therapy|March 12, 2021
Prognostic Implications of the Complement Protein C1Q and Its Correlation with Immune Infiltrates in OsteosarcomaHanji Huang, Manli Tan, Li Zheng, et al.Oncotargets and Therapy|April 21, 2017
The world of targeted therapies in kidney cancers: pitfalls, tips and tricksAlexis Vallard, Jane-Chloé Trone, Julien Langrand-Escure, et al.Oncotargets and Therapy|April 21, 2017
Nonalcoholic steatohepatitis-related hepatocellular carcinoma: is there a role for the androgen receptor pathway?Mahmoud A Ali, Sahin Lacin, Reham Abdel-Wahab, et al.Oncotargets and Therapy|July 16, 2019
PRPF40A as a potential diagnostic and prognostic marker is upregulated in pancreatic cancer tissues and cell lines: an integrated bioinformatics data analysisZhen Huo, Shuyu Zhai, Yuanchi Weng, et al.Oncotargets and Therapy|July 16, 2019
Monoclonal antibody AC10364 inhibits cell proliferation in 5-fluorouracil resistant hepatocellular carcinoma via apoptotic pathwaysJianzhong Wu, Junwei Qu, Haixia Cao, et al.Oncotargets and Therapy|July 17, 2019
Preparation of highly activated natural killer cells for advanced lung cancer therapySilun Xie, Zhenyi Wu, Lizhi Niu, et al.Oncotargets and Therapy|July 17, 2019
Dietary natural astaxanthin at an early stage inhibits N-nitrosomethylbenzylamine-induced esophageal cancer oxidative stress and inflammation via downregulation of NFκB and COX2 in F344 ratsLingling Cui, Fan Xu, Minkai Wang, et al.Oncotargets and Therapy|July 17, 2019
Targeted therapy and personalized medicine in gastrointestinal stromal tumors: drug resistance, mechanisms, and treatment strategiesGeorge Z Li, Chandrajit P RautOncotargets and Therapy|October 31, 2022
In vitro Characterization of Enhanced Human Immune Responses by GM-CSF Encoding HSV-1-Induced Melanoma CellsMaike Delic, Veronika Boeswald, Katrin Goepfert, et al.Pageof 671